{
    "id": "jmkhlf63rw7kz6ygsvwrqwov7arcyc2j",
    "title": "The Importance of Reproducible Research in High-Throughput Biology: Case Studies in Forensic Bioinformatics",
    "info": {
        "author": [
            "Keith A. Baggerly, Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston"
        ],
        "published": "Oct. 11, 2010",
        "recorded": "September 2010",
        "category": [
            "Top->Computer Science->Bioinformatics"
        ]
    },
    "url": "http://videolectures.net/cancerbioinformatics2010_baggerly_irrh/",
    "segmentation": [
        [
            "OK, so thank you for sticking around for the very last session we're in the homestretch, they really appreciate you being here, so that's very good thing and I want to talk a lot about a theme that we haven't focused on explicitly in this conference so far, which is the importance of reproducible research in high throughput biology as these were generating better and better assays and we're generating more and more measurements, thousands of things, it becomes increasingly important since the analysis takes a larger and larger chunk of time that.",
            "At some stage not only us, but others should be able to precisely reproduce what we did.",
            "In other words, if they start with the same numbers, should they get the same results and we'd like that to be true.",
            "Now this is actually really important in high throughput biology for a somewhat different reason, which is simply that.",
            "And once I will get this advance then we will tell you what it is, let's see.",
            "OK, well I can gesture and I can tell you what it is, which is simply that our intuition about what makes sense in high throughput biology actually is pretty darn poor.",
            "What I mean by that is that in many cases I've worked with clinicians where I've gone in and I've said this gene has gone up and that means these people are most more likely to develop."
        ],
        [
            "Advanced cancer and the clinician is turned to me and said no.",
            "What that means is that you've got stromal contamination in your samples, 'cause I've worked with that gene for 15 years and I know how it behaves and they're right.",
            "They have intuition for single jeans.",
            "On the other hand, if I go to that same clinician, I give him the following signature of 100 jeans, and I say this goes up well.",
            "They'll stare at this list of 100 genes and they'll say, yeah, I can see that 'cause this will influence this, and this will influence this.",
            "It's wonderful.",
            "It's a Rorschach test for biologists to give them a gene list of 100 things.",
            "And unfortunately, we've tried the null experiment of giving a random list to some of our biologists, and they still find patterns, so this is somewhat of a warning.",
            "Now in light of this, we find it somewhat dismaying that when we go to the literature and we take a take, a typical paper and we try to figure out what was done, the documentation is often poor.",
            "And if the documentation is poor in some cases, if the finding is important, we are forced to resort to what we have come to refer to as forensic bioinformatics, which involves.",
            "Starting with the results and the raw data and saying what must they have done to get from one place to the other regardless of what the method say they did OK and I want to illustrate this and how important this might be by considering his specific clinical example specifically using signatures, genomic signatures to try to predict response to chemo sensitivity."
        ],
        [
            "And this is actually based on work that appeared a few years ago.",
            "Now at the end of 2006.",
            "This is a paper that showed up in nature medicine and what they said what they claimed in this paper was that they figured out a really great thing specifically starting with cell lines.",
            "They figured out how to come up with genomic signatures of sensitivity to a whole bunch of drugs.",
            "So here's how this worked.",
            "They're not just working with any panel of cell lines, they're working with the NCI 60 in the NCI 60, as was alluded to in the last talk, is a very special thing.",
            "One reason it's very special.",
            "Is that it's a standard panel maintained by the National Cancer Institute, and what that means is that if you've got a new chemotherapeutic, that agent will be sent to the National Cancer Institute and they will test it for efficacy against this panel of 60 cell lines, and that that information about which drugs are most effective against with cells.",
            "That's public data, you can go and you can download it, and you can download this information for every single chemotherapeutic now available.",
            "So if you can figure out how to leverage that information, that's potentially way to use.",
            "Or choose the best single drug that's out there for a given patient.",
            "So what they said was they said OK for using the NCI 60.",
            "Let's start with the drug of interest, like docetaxel.",
            "Let's pick the send most sensitive and most resistant cell lines.",
            "OK, those are our extremes.",
            "Let's take array profiles of those cell lines.",
            "OK, fine, let US contrast them and identify the genes that are most different between Group One and Group 2.",
            "These jeans will comprise elements of our sensitivity signature.",
            "And then they say let's different model to come up with this sensitivity.",
            "Signature Ann.",
            "For doing this they use.",
            "Meta genes, which sounds really cool, but to mathematicians we otherwise noted no.",
            "It is principle components and I'm going to use that terminology and they're going to say OK.",
            "Using these metagenes, let's try to fit the fit that at the cell lines and predict on clinical samples.",
            "And they tried this with a whole bunch of public datasets using seven commonly use ages.",
            "They reported great results and I know this was really splashy because within two weeks of this paper appearing we had three different groups of MD Anderson coming to us in bioinformatics and saying we want to do this.",
            "Help us do it, and being helpful bioinformaticians, we said.",
            "Well.",
            "Sure, we'd love to do that, and in particular, since all of the data involved is public, we should be able to go out and figure out how to do it ourselves and generalize it to other trials.",
            "OK, so let's let's try that and we decided to try that.",
            "Starting with those attacks.",
            "So we starting with the most sensitive and most resistant cell lines.",
            "In this case, we're going to be using you 95 a raise for the NCI 60 these arrays were run in triplicate, so we've got 3 for each and when we did this and we."
        ],
        [
            "Tried to fit the training data.",
            "Here is a plot of the first 2 principal components of these things and what you can see.",
            "Not too surprisingly is that you have some pretty clear separation between all the resistant ones at the left and all the sensitive ones at the right.",
            "This little triangle of three things.",
            "Those are three replicates in the same cell line, so that's sort of what we expect to see now.",
            "This separation should not surprise you.",
            "This is the training set we have picked the genes specifically to achieve this separation.",
            "What we now want to see is we now want to say clinical samples project it into this same space.",
            "ANSI, this separation so that we can use it ourselves.",
            "So we took the predicted the actual patient information and we projected."
        ],
        [
            "Into this space.",
            "And we did not see the separation that we were really hoping and expecting to see.",
            "So of course this led to the natural question of did we do something wrong?",
            "And this is of course without.",
            "Now we're going to start to reconstruct exactly what was done, and to do this, we began by saying, OK, well, OK. What were the signatures or the specific genes that they used for the individual drugs?",
            "And this is actually somewhat easy because in the supplementary material to their paper they included here are the lists for each drug of all the Affymetrix probe set ID's that are involved in all the genes that are involved.",
            "And into the paper they also gave some explanations about.",
            "Here are some genes that make sense in the context of this drug, because it explains the biology and so on like that.",
            "So OK, so we decided to pick one of the drugs and we started with five fluorouracil.",
            "And what we?"
        ],
        [
            "I want to be able to do with this is we want to be able to construct a heat map that looks like this.",
            "This is a heat map that actually showed up in the paper.",
            "This is up the 45 genes that they picked out for five fluorouracil and one of the things that you can see is this Plaid pattern.",
            "Because everyone of the 45 genes has a pattern that we like with another resistor high in one group and low in the other or low then high so OK, extreme separation, that's what we expect.",
            "That's what we want in the cell lines so well, how they pick these?",
            "Well they pick these using 2 sample T tests and I'm a PhD level statistician, so I figured out how to do 2 sample T test by this point."
        ],
        [
            "So we tried it ourselves, so here's our best 45 using T test so OK great and then we said, alright, let's take the list of Affymetrix probes that ideas for their 45 and taken."
        ],
        [
            "That heat map and.",
            "We didn't see again what we were expecting to see, so we then decided to try something which we've learned to unfortunately do.",
            "Every once in awhile, which has been just a bit paranoid about the data and what we did then was.",
            "We took our list and there's an we."
        ],
        [
            "Put them side by side so there's their list and there's ours.",
            "Does anybody notice a pattern here?",
            "What we have here is indeed an off by one indexing error.",
            "This is true for all of the genes in this signature.",
            "Now, what does that say to you about whether or not certain genes making sense in terms of the biology really holds when they're referencing a set of genes that actually isn't involved?",
            "So now, of course, this is just one drug.",
            "They looked at 7, so there's six others.",
            "So what we decided to do for these six others, we basically took their reported at the IDs, move down one.",
            "An looked at the P values to see if they were really small."
        ],
        [
            "So let's see.",
            "Well, topotecan.",
            "Yet they're all off by one etoposide off by one adriamycin, mostly off by 1.",
            "There's a few.",
            "We can't explain paclitaxel, mostly off by one docetaxel, mostly off by one and cytoxan.",
            "We have no earthly idea what they did with this drug.",
            "So, OK, fine, we've got this, and we know that that's one problem.",
            "Now, how is it that this problem could arise?",
            "And to answer that one, we went in and we looked at the software that they were using, and as a side note, if you want to read documentation on how this software works.",
            "You should go to our website because I wrote it because we couldn't find any."
        ],
        [
            "And one of the things that we noted was that their software, in order to work, required two input files.",
            "The first input file is the quantification matrix genes by samples, and this matrix needs a header row where the header is either 0, one or two to indicate that this is a training sample.",
            "Sensitive training, sample resistant, or a test sample whose outcome we don't know.",
            "That's the first input, the qualification matrix.",
            "The second input is a list of Gene IDs.",
            "Gene names in the same order as in the quantification matrix.",
            "What for their software to work correctly?",
            "This second input must not have a header row, so if you start with an Excel file and you copy and you paste an, you've got to take title at the top.",
            "It says gene name.",
            "Guess what happens, you will get an off by one indexing here, and if you run this through your software, we tried this with those attacks and we perfectly matched the heat Maps and we also got some of these offset jeans, so we know that works.",
            "But again, that's one drug docetaxel out of seven.",
            "So what happens?"
        ],
        [
            "The other six.",
            "Well, let's take a look.",
            "OK, Topotecan, we can perfectly match the heat Maps.",
            "We know what cell lines are involved.",
            "We know what jeans they should be producing.",
            "OK, fine, Adrian myosin perfectly total site, perfect five fut perf.",
            "Paclitaxel.",
            "Well, they mislabeled to cyclophosphamide in the paper, but OK. Cyclophosphamide, we still have no earthly idea what they did with this.",
            "So OK, there's things that we can perfectly match the heat Maps for six of the seven drugs.",
            "We understand what they did now.",
            "Actually before we go on, I should note that this should actually bother you.",
            "And the reason it should bother you is that we've perfectly matched the heat Maps for six of the seven drugs, but we managed to perfectly match the gene lists for only three for four of the drugs.",
            "There are included other genes that we can't explain just yet."
        ],
        [
            "They are outliers and we'll come back to those because before we get there we also noticed in using their software that something that was more important to us, which was that their software also gave predictions and this is the clinical thing that we're really interested in.",
            "We want to know is this patient going to be sensitive or not?",
            "So we wanted to see can we get good predictions out of this software and the way we're going to check this?",
            "Well, there's a bit of a problem in the paper.",
            "Doesn't say for the fitting datasets that they fit this patient turned out to be sensitive.",
            "This one resistant.",
            "Now they just gave us an overall.",
            "Rate of accuracy.",
            "OK, so that they got.",
            "If they've got 24 patients they got 22 of them right?",
            "OK, fine, so we're going to say that we understand the classification algorithm or this thing well enough to use it.",
            "If we can get accuracies at least as good as the ones that they report, OK, that's our bar.",
            "So that of course brings."
        ],
        [
            "The next question, which is just how good are the accuracy rates that they obtain, so we're going to look at this in the context of docetaxel and this top plot is a figure from the paper, and you can see the scores for the sensitive patients, and they are mostly low with blue squares.",
            "That's good, resistant ones, are high, and they've got red triangles, and that's good, and I have a question here.",
            "I have an analysis question for the audience.",
            "The analysis question is how many blue squares are there?",
            "13 that is correct.",
            "We have up there in the top pot.",
            "13 sensitive samples, an 11 resistant ones.",
            "Now there's a second panel on this page right here.",
            "The thing is, this panel doesn't come from this paper.",
            "This panel comes from a paper by Chang at all.",
            "They are the ones that actually introduced the test set being analyzed here.",
            "And according to Chang at all, they thought that they had 11 sensitive and 13 resistant.",
            "So 1311 or 11 and 13.",
            "That may be a problem, so we decided to take a look at a different drug, namely adriamycin, and for those of you who are real math with."
        ],
        [
            "Is here how many red triangles are there OK for those who aren't quite that ambitious?",
            "Are there more red triangles or blue squares?",
            "Come on, this is not a trick question.",
            "I hear red triangles or with both.",
            "So basically we've got a whole bunch of patients that are resistant to therapy.",
            "The problem is, in this case the underlying data set that's applied this thing.",
            "This was from a paper on childhood leukemia.",
            "The reason this is a problem is that childhood leukemia is a disease for which we've actually got a pretty good cure rate, around 80%, and what that means is that if we've got a drug to which most of the patients are resistant, we wouldn't be using it.",
            "And indeed, if we go back to the original paper that submitted it, they thought that most of their patients were sensitive.",
            "So what do we think is going on?",
            "We think that for zero and one they swapped the interpretation in feeding it into the data and they didn't realize what they were doing.",
            "Now what does this mean?",
            "Clinically, it means that what well, they're going to use that signature, and they're going to administer adriamycin just to the patients who will derive no benefit from it.",
            "This is poor clinical practice, so we don't think this is a good idea.",
            "So given this, there is the question of OK if they're mixing things up this badly, how is it that they're getting good predictions in the 1st place?",
            "And actually, this leads back to one of the things that we passed on just."
        ],
        [
            "A few minutes ago, which is that there were some other jeans, and in particular for docetaxel, there were 50 jeans.",
            "If we take our list of docetaxel, and we do this off by 1 trick, we match 31.",
            "That leaves 19 of these.",
            "19.",
            "There's the question of where can they come from?",
            "Well, if you go back to the initial paper by Chang at all, that supply the test set, they say if you want to separate our resistance from our sensitives, here's a list of 92 genes that will do the job.",
            "So we said, OK, let's take a look at the 19.",
            "We can't match and compare them with the 90 two they report.",
            "And we find out that there is an overlap of 14 jeans.",
            "There you go, there are entries 7 through 20 in this list, one contiguous block.",
            "I think we have some statisticians in the audience.",
            "So quick question.",
            "If I pick 14 items at random from a list with 92 in it, how often do they all appear right next to each other?",
            "The P value is small.",
            "You can get published with this one.",
            "OK, now first this still leaves 5.",
            "One of the other five.",
            "Will the RCC one IRCC for Herb, two, BCL 211 and two or three.",
            "The thing that the common theme of these five.",
            "Is that these are the genes mentioned by name in the paper to explain why the signature works so for the docetaxel signature we have the genes that work to split the test set, the jeans that work to split the training set and the jeans that are there to explain why it works.",
            "And there is no overlap between these three.",
            "We thought this was somewhat disturbing, so we wrote a letter to Nature medicine."
        ],
        [
            "One of the things about this being a talk on reproducible research is that you don't have to take my word for it, which means that you can go to nature medicine.",
            "You can read the paper.",
            "You can also read our reports which contain all of our code.",
            "You can run it through our and you will get the same numbers we do.",
            "As a side note, for data compression are note to nature.",
            "Medicine is 700 words.",
            "There's 140 pages of supplementary material for those 700 words there, so there's a bit of a compression there, so that was fun, and so all the data is there.",
            "And then of course we wanted to see OK is their response.",
            "So they say Oh well, whoops, we got it wrong, will fix it next time.",
            "Won't know that wasn't quite the response."
        ],
        [
            "The response was well, unfortunately, the analysis of Baggerly and Coombes is deeply flawed, and a bunch other errors.",
            "Well First off, for Adrian myosin, the labels.",
            "This is the one where they have a lot of red triangles.",
            "The labels are actually correct, and we've posted details on our website to illustrate this and they must be wrong because we've gotten this approach to work again and in their rebuttal, they note that they've done it twice in new papers with editorials and things like that, so we must have screwed up and well, given the timing.",
            "I'm not going to be able to go through.",
            "All of these, but I want to look at some of the data for one or two of these.",
            "Just just illustrate what might be going on.",
            "So let's start with Adrian myosin for Adrian myosin.",
            "They say they've got the labels correct on their website, so we went to their web page and we said what's there?",
            "Well, actually, when we went there, we saw that there were there's a table of qualifications for 144 samples, 22 for training cell lines, and 122 for test.",
            "These are the patient ones for which they're making predictions, and we said, well, maybe we can find something that separates the responders from the non responders.",
            "So we decided, let's try to cluster it, and as a prelude to that.",
            "Let's just check the correlations between individual pairs of elements and."
        ],
        [
            "I'm going to show you now is a plot of all the really high correlations we see in this matrix of 144 samples.",
            "Here's the submatrix corresponding to the training data, the cell lines.",
            "And here's the test data.",
            "Now the red line on the main diagonal we expected samples are indeed highly correlated with themselves.",
            "That's good.",
            "However, we didn't expect these red dots off the main diagonal.",
            "What's going on?",
            "Well, turns out they had 122 test samples.",
            "But the 122 are not all distinct.",
            "There are some samples that they have reused 2, three, or even four times, and there's a sample right about here which has been reused four times, which has been labeled as resistant three times out of four.",
            "Now that's the same sample, so we're pretty pretty convinced that the labels are not all correct even now.",
            "So we sent a further note to Nature Medicine about this and nature medicine forwarded this onto the authors, and then they got back to us and said, well, they'll adjust it, so we see no need to publish your note.",
            "OK, fine.",
            "And indeed."
        ],
        [
            "What they said later in August of 08 was that they had redone the analysis using only the 95 unique samples, and again gotten great results.",
            "Now, for those of you who are listening to me carefully before you will recall that, I said that there were actually 84 distinct samples.",
            "So hearing that there were 95 was a bit of a surprise to us.",
            "So, OK, but fine.",
            "And what they do now.",
            "Well, when they corrected this in August, oh wait, they actually took down the qualifications and they just put up a list of the 95 Geo ideas of the arrays involved.",
            "So let me show you the 1st 20 of the 90s."
        ],
        [
            "They now list.",
            "And I've highlighted a few of them because that seems twice that seems twice this ones whose twice and labeled both ways.",
            "So actually of the 95 which is.",
            "This is the second correction, by the way, 15 are in duplicate of those, 1566 are labeled both ways, and Furthermore, since they've actually notes now, told us the Geo ideas of the individual arrays, we can actually go back and figure out what the initial submitters thought they were in terms of resistant or sensitive.",
            "So the group that the Duke Group says that 61 or resistant.",
            "13 or sensitive and six.",
            "We don't know.",
            "The people submitting the data set up at 22 or resistant 48 were sensitive and tend they labeled as intermediate.",
            "They didn't classify him.",
            "So for Adriamycin, we're not convinced this works well alright.",
            "There's still other things that they put out there.",
            "There's other paper."
        ],
        [
            "With editorial so let me show you one of those.",
            "This is a paper that showed up in the Journal of Clinical Oncology by Sue at all and in this paper they extended the approach to deal with two new drugs, cisplatin and pemetrexed.",
            "It these are important in treating lung cancer and one of the things that they thought was really neat was they said OK, we actually don't like the NCI 60 for all drugs so we're going to shift to a different set of cell lines and these cell lines were profiled on Matthew 133 arrays and one of the things that they did using this was they came up with the signature versus platinum versus platinum.",
            "They pointed out something important specifically that the signature they found contained.",
            "GRCC 1 ERC C4 in DNA repair genes.",
            "That's important because there have been several papers in the New England Journal saying these are related to how you treat lung cancer.",
            "So that's really cool.",
            "So what we do?",
            "Well, we took the data and we said alright, let's try to see if we could match the heat map so we know the cell lines and the genes involved and after with some work and that's another compression thing there.",
            "We did manage to exactly match the heat Maps and for cisplatin after we exactly match the heat map, we took a look at the genes involved an we discovered that we could match.",
            "41 of the 45 genes they report after accounting for this off by 1 error that still there, there's four that we can't match at all.",
            "Do I have any guesses from the audience as to the identities of those four?",
            "The form that we."
        ],
        [
            "Cannot match RERC C1 ERC C4 RCC one again.",
            "In fact an up these for the last two are special because as it turns out those two aren't on the 133 arrays there on the 133 B, so two of their best jeans they haven't measured yet.",
            "But hey, who needs to conduct experiments?",
            "If you know the answer this is a wonderful finding.",
            "OK, great so we were disturbed by this.",
            "As a side note, we submitted a correction for this one to JCO and they sent us a note back saying we're sorry we can't publish this and we said OK fine and over the next few years what?"
        ],
        [
            "What went on from there is that there were other papers that kept on coming 070809 but middle of last year we learn something new that sort of disturbed us and what we learned middle of last year."
        ],
        [
            "Wasn't it already started running clinical trials using these rules to allocate patients to treatment arms?",
            "They're doing this using pemetrexed and cisplatin, pemetrexed and Viorel, being docetaxel, doxorubicin and for several of these drugs.",
            "These are in cases where in the posted signatures they've gotten the sensitive and resistant labels reversed so we think this is a problem so we wrote up a paper on this.",
            "We first circulated it to a biological Journal and got the comment back that we're sorry this story.",
            "The story seems to negative.",
            "Can you fix that?",
            "At which point we said, well, we."
        ],
        [
            "Probably count, so we sent it off the hours of applied statistics on the 1st of September, it was accepted and published online by the 14th, at which point was covered by the press.",
            "Duke starts an internal investigation and suspended the trials pending the outcome of the investigation.",
            "That was October of last year.",
            "So what?"
        ],
        [
            "Next as of the end of January of this year.",
            "Duke decided to restart the trials, and in particular they said that their investigation, which was now concluded, had strengthened their confidence in this evolving approach to personalized cancer treatment.",
            "Now we were not really pleased by this and the main."
        ],
        [
            "Reason we were not really pleased is that we ask them.",
            "Well, OK, we don't understand that it can.",
            "You show us the data and stuff that you used to come to reach this conclusion and they said, well, no.",
            "While their reviewers that conducted these things approved are sharing our report with the National Cancer Institute, we consider it a confidential document.",
            "So now you can't see it.",
            "Which disturbed us and as a side note there."
        ],
        [
            "Just one more thing.",
            "Which is that this investigation took place between October and January.",
            "Well, as it happens in November, something new happened.",
            "In November, they posted data.",
            "They posted new data for one paper dealing with cisplatin and pemetrexed.",
            "These are two of the drugs.",
            "They're using clinical trials.",
            "An in this data, they said, here are the 59 samples that were using as a validation set to show that this works.",
            "These 59 samples are a subset of this one Geo data set and we're using it to make predictions.",
            "So we said, OK, cool, we see these 59 samples.",
            "We've got the ovarian ones.",
            "Let's go in and take a look at them.",
            "So the very first thing we did with these 59 samples we said let's go back to the Geo data set and see if we can match them up."
        ],
        [
            "And when we did, here's what we found.",
            "So what if the names matched up for all the for all the 59 samples we should see 59 red squares lying on this blue diagonal line.",
            "How many red squares do you see lying on that blue diagonal line?",
            "This is not a hard counting question.",
            "None.",
            "40 three of the samples they got the labels wrong for 16 they didn't get the labels wrong, or at least the problem is for these 16.",
            "We can't tell the reason we can't tell us that for those 16, they've scrambled the gene labels so badly that we don't know what samples they correspond to.",
            "What this means is that for their validation data set, every single sample is incorrect.",
            "For two drugs they've been using in clinical trials for two years.",
            "We think this is disturbing.",
            "So what happened next?",
            "We pointed this out at the end of January.",
            "No response, so we then said can we do anything else and it occurred to us that they said, well, we won't show you the report, but the reviewers approved of us sending it to the NCI.",
            "Now the NCI in the US is a federally funded institution and what that means is that they are subject to federal law specifically."
        ],
        [
            "The Freedom of Information Act.",
            "So in April we filed a request with the NCI to get the report under the Freedom of Information Act and at the start of May they redacted version of the report was indeed supplied and we looked at it.",
            "We found a few things that were rather interesting in the report or weren't in the."
        ],
        [
            "Report the two main things that we found were the First off the review committee that went through this stuff.",
            "The people have Valuated said by the way we couldn't figure out from the data that's been published how to do this.",
            "The only way we got it is because there was extra information supplied to us and we really recommend that the investigators make that public.",
            "So that's one thing.",
            "The other thing that we found rather disturbing what wasn't there specifically?",
            "This report makes no mention of those problems with cisplatin pemetrexed that I just told you about.",
            "It's not there so we pointed this out in May and also in May.",
            "We ask the National Cancer Institute what do you think about what's going on and well they said.",
            "Let's look at the trials.",
            "We actually don't fund those three clinical trials."
        ],
        [
            "You found another one.",
            "That's a phase three and actually based on that they re investigated the rationale and they yanked that signature from the phase three clinical trial in the middle of the trial.",
            "That's mid may we said, OK, is there anything further that's going to happen with these with the three ongoing trials at Duke, nothing happened.",
            "Nothing happened for two more months and then in mid July we found out something new that's a bit orthogonal from your normal status."
        ],
        [
            "One of the puppies used to claim he was a Rhodes scholar.",
            "The Rhodes Trust in Britain says no, no, he wasn't.",
            "Indeed, it appears there was some CV fudging involved.",
            "Now, what happened then was that I knew that there were a few statisticians have been talking about saying maybe we should write a letter or something.",
            "So I emailed a few of them the day this came out and said, you know, if you want to write a letter, now is about the best time, so the following."
        ],
        [
            "Day three days later, there was a letter from 3133 Biostatisticians find a few that you like.",
            "Cancer Letter comments that Dukes administrators have accomplished something monumental.",
            "They triggered a public expression of outrage from Biostatisticians who cool.",
            "But the fun thing about this letter was that it went to the newly appointed head of the National Cancer Institute, Harold Varmus, and to Duke and to the DoD and to the press.",
            "So this one got some coverage.",
            "So what happened?"
        ],
        [
            "Duke suspended the trials.",
            "This has since been covered just a bit in a few other outlets like NPR, Science, Nature and some other fly by night journals and a few other investigations are underway and there's actually a new Google Group devoted entirely to reproducible research and things like that.",
            "But as we've been looking at this, there is a caveat that I think we should keep in mind, and that caveat is that unfortunately, some of these mistakes like the."
        ],
        [
            "For one, we've seen them before.",
            "This is not the only time we've seen some of these examples going back to 2002, 2003, 2005.",
            "These types of errors have been around for a while.",
            "This isn't egregious combination, but the problems are there, so some observation."
        ],
        [
            "Jones the most common mistakes are simple ones.",
            "For example, in statistics.",
            "The simplest one here for genomics is complete confounding of the experimental design.",
            "Others involved mixing up sample labels, gene labels, things that are easy to do in Excel.",
            "OK, those are easy to mistake.",
            "Now the fun thing about simple mistakes is that if you see them, they're easy to fix.",
            "But if the documentation is poor, you won't see them, so they will slip by because our intuition is no good.",
            "And what that means is that if you go out to the literature.",
            "We sort of suspect that the most simple mistakes are more common than we would like to admit.",
            "Now what would we?"
        ],
        [
            "Like to have happened.",
            "Well for papers we've got a little thing of saying, here's some things we really would like to see in addition to data like this stuff at Geo, we'd really like some idea of if you're going to supply us with a table of quantifications, please label the columns.",
            "Tell us which samples are which, and provide code so these are some other things, and these are recommendations for papers, but we think they should be actually absolute requirements before you start clinical trials.",
            "Now do we.",
            "As the phrase goes, walk the walk."
        ],
        [
            "Did we do well?",
            "Partially in response to this.",
            "About in early 2007, Kevin Coombs and I went into our our Department of Bioinformatics with MD Anderson.",
            "We said guess what?",
            "Henceforth we are announcing by Fiat that all reports that we write are now going to be written in S we've combination of are in LA Tech.",
            "The fun thing about us we've is that you can take these reports.",
            "You can run them through our.",
            "Somebody else can run them through our and get the same numbers.",
            "As a side note, most of our reports now go are written by stat analyst.",
            "Faculty member teams.",
            "The analyst writes the report submitted to the faculty member of the Faculty member proofread it reruns the code if necessary, and only after the second approval does it go off to the biological Pi.",
            "This is actually helped our reproducibility quite a bit.",
            "So actually if you ask us what we did in any report, going back for about 3 years now, we can tell you exactly we find that useful, But the buzz phrase in all of this is reproducible research Now, so I've given you some observations and I've told you lessons that I really want you to drive from it.",
            "So I have one last slide and that is to ignore."
        ],
        [
            "Lidge some folks so Kevin Coombs is my primary coauthor in all these things.",
            "Some other folks at MD Anderson, the various groups that provided money at MD Anderson.",
            "And of course, if you want to read more, you can go to the annals of Applied Statistics and you can read the paper.",
            "You can look at the code.",
            "Even better, you can cite the paper 'cause that'll make me famous and my mom happy and she can buy me more micro ties for Christmas and I have one last acknowledgement wishes to you.",
            "My kind audience for bearing with me for the past half hour.",
            "And that's what I got.",
            "Thank you.",
            "Thank you very much.",
            "There must be questions.",
            "OK, for things that would be appropriate for going to clinical trials.",
            "First off, the rule needs to be specified sufficiently precisely that an independent person outside of that group can rerun it and get the same numbers.",
            "Since lots of clinical trials are on institutions with their own Institutional Review Board, it should be specified clearly enough for a representative of that Institutional Review Board to run it and get the same numbers.",
            "This will typically be a biostatistician at the Associated Cancer Center.",
            "They should be able to do that in going from one going from.",
            "In particular cell lines, etc.",
            "We would really like to see this replicated in an independent data set, at least one beyond the one that you've got.",
            "The other one thing that we toss in that, just as a caveat to guard against some of the confounding issues that we've talked about, in particular for any finding that we that we look at that says, wow, this is wonderful.",
            "Our first reaction at this point is OK. What type of batch effect did we miss?",
            "So we tend to take the jeans that are most interesting.",
            "And before we use them, we plop them as a function of run date.",
            "Simply to see, do we see obvious batch effects that might cause us to be curious, but those are the very quick and dirty things that I can think of.",
            "There's a more extensive list, but that will take longer to explain, OK?",
            "This is actually made a comment.",
            "We saw similar situation in in less.",
            "A critical issue like Self Line and things to experiment like that that we use using meta analysis from things coming from the geodatabase.",
            "Unfortunately one of the main problem I think is related to the fact that the vast majority of the reviewer of the biological Journal will trust all the part related to the micro analysis and we completely skip it simply they.",
            "Take the final results and they evaluate out those fits to the evidence that are coming from the wet lab, and this is actually the problem.",
            "When I review some of these microarray paper normally the first time I have always to ask for extra information, but are never enough in the in the methods.",
            "But this is a general situation for everything that is handled by the biological reviewer.",
            "Actually, that's a general problem that's not the whole problem, in part because.",
            "There is no way that any individual reviewer could have caught all the problems that we talked about.",
            "'cause that involves detailed examination of the raw data.",
            "What we do ask right now when we when I'm reviewing papers for example is I look and say alright, do they tell me where the data is?",
            "Do they give me a URL or something?",
            "Do they tell me where I can find the code?",
            "Are the links actually live?",
            "Can I see it?",
            "I don't go through and check it for accuracy at that time, so that's a bit of an issue.",
            "We are actually in the process of talking to a large number.",
            "Journal editors and funding agencies, even now to say guys we need to fix this.",
            "So actually some of this is going on with the editors of the nature family 'cause they're not too happy that this showed up in nature medicine.",
            "For some reason, they're saying, OK, we'd like to fix that.",
            "How can we fix that?",
            "One of the things that we're looking at is both specifying a minimal set of things.",
            "That's that short note up there, but the other thing that we're talking about is for some papers, one of the ideas that we've been bandying about is having, in addition to, say, a specified statistical review.",
            "In some cases, having a specified reproducibility review and saying if you've got something particularly in the New England Journal or Nature Medicine where it might lead to a clinical trial, you send it off to a group and say, OK, your job as a reviewer is simply to run the code and say does it generate the figures that show up in the paper?",
            "Does it do that?",
            "And that's going to delegate the workload and may if people know that it's going to be checked for reproducibility before it's published, the chance of actually getting that code and documentation is orders of magnitude better, so that's.",
            "Our best fixed that yes it is a problem, but we're trying to address that.",
            "OK, so you gave one very detailed example of one group which both was appalling in its systematic aspects.",
            "Ann and the implications of the clinical trial.",
            "But how often?",
            "I assume that that's not the only thing that you tried.",
            "How often do you see such mistakes on this example?",
            "We have frequently seen mistakes that involve column transpositions, Rd transpositions in some cases with quantification, matrices, column offsets, and I've seen these in datasets that have come to me within MD Anderson.",
            "You will never see these datasets.",
            "They have never left MD Anderson before I fixed them.",
            "They we have also seen these in other papers in the literature.",
            "Most of the time you won't see us talking about those too many because we haven't looked at anywhere at most of them anywhere near this level of depth, and we can't because actually reconstructing this takes a hell of a lot of time.",
            "We estimated that this took us somewhere between 1500 and 2000 hours to figure out how all this worked.",
            "And the only reason we went into that level of detail here was because of the direct clinical application.",
            "And because of the requests from clinical peas at MD Anderson.",
            "We know that some of the simple mistakes are common.",
            "I won't even as a first pass, I tend not to try to use too many micro experiments before 2005 because the rate of complete confounding is so high.",
            "If you've got Affymetrix datasets, one of the things you can do from the cell files, as you can pull out the run dates from the headers and you can plot things that way to see if that's a problem.",
            "Yes, there are other simple problems like that.",
            "We know that they are more widespread than just this example.",
            "So we know it needs to be fixed.",
            "We still refer to this as our example case study because it tends to focus the attention.",
            "Colin has a question.",
            "We've had this sort of problem elsewhere.",
            "Ions in science and one policy.",
            "It was sort of adopted is that two separate groups who do not interact actually analyze the data or derive the theorem whatever, totally separately, because when people make mistakes, so tend to fly off at a tangent all over the place, so they do not make the same mistake if they're totally separate groups.",
            "So it's a reasonable strategy that is a reasonable strategy, particularly if you're just talking about the analysis actually, to a certain extent, having somebody else be independently able to reproduce the analysis as I was just mentioning for an IRB approval.",
            "That's one thing that we would really like to see in particular before going to clinical trials.",
            "Having some other group try to at least qualitatively reproduce the findings as qualitatively not just exactly reproduce the analytical results that would.",
            "That's also something we would find very reassuring, so we would love to see it.",
            "It's not often done.",
            "OK.",
            "So thank you again.",
            "Not only for the talk, but also for doing all that work."
        ]
    ],
    "summarization": {
        "clip_0": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "OK, so thank you for sticking around for the very last session we're in the homestretch, they really appreciate you being here, so that's very good thing and I want to talk a lot about a theme that we haven't focused on explicitly in this conference so far, which is the importance of reproducible research in high throughput biology as these were generating better and better assays and we're generating more and more measurements, thousands of things, it becomes increasingly important since the analysis takes a larger and larger chunk of time that.",
                    "label": 0
                },
                {
                    "sent": "At some stage not only us, but others should be able to precisely reproduce what we did.",
                    "label": 0
                },
                {
                    "sent": "In other words, if they start with the same numbers, should they get the same results and we'd like that to be true.",
                    "label": 0
                },
                {
                    "sent": "Now this is actually really important in high throughput biology for a somewhat different reason, which is simply that.",
                    "label": 0
                },
                {
                    "sent": "And once I will get this advance then we will tell you what it is, let's see.",
                    "label": 0
                },
                {
                    "sent": "OK, well I can gesture and I can tell you what it is, which is simply that our intuition about what makes sense in high throughput biology actually is pretty darn poor.",
                    "label": 0
                },
                {
                    "sent": "What I mean by that is that in many cases I've worked with clinicians where I've gone in and I've said this gene has gone up and that means these people are most more likely to develop.",
                    "label": 0
                }
            ]
        },
        "clip_1": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Advanced cancer and the clinician is turned to me and said no.",
                    "label": 0
                },
                {
                    "sent": "What that means is that you've got stromal contamination in your samples, 'cause I've worked with that gene for 15 years and I know how it behaves and they're right.",
                    "label": 0
                },
                {
                    "sent": "They have intuition for single jeans.",
                    "label": 0
                },
                {
                    "sent": "On the other hand, if I go to that same clinician, I give him the following signature of 100 jeans, and I say this goes up well.",
                    "label": 0
                },
                {
                    "sent": "They'll stare at this list of 100 genes and they'll say, yeah, I can see that 'cause this will influence this, and this will influence this.",
                    "label": 0
                },
                {
                    "sent": "It's wonderful.",
                    "label": 0
                },
                {
                    "sent": "It's a Rorschach test for biologists to give them a gene list of 100 things.",
                    "label": 0
                },
                {
                    "sent": "And unfortunately, we've tried the null experiment of giving a random list to some of our biologists, and they still find patterns, so this is somewhat of a warning.",
                    "label": 0
                },
                {
                    "sent": "Now in light of this, we find it somewhat dismaying that when we go to the literature and we take a take, a typical paper and we try to figure out what was done, the documentation is often poor.",
                    "label": 1
                },
                {
                    "sent": "And if the documentation is poor in some cases, if the finding is important, we are forced to resort to what we have come to refer to as forensic bioinformatics, which involves.",
                    "label": 1
                },
                {
                    "sent": "Starting with the results and the raw data and saying what must they have done to get from one place to the other regardless of what the method say they did OK and I want to illustrate this and how important this might be by considering his specific clinical example specifically using signatures, genomic signatures to try to predict response to chemo sensitivity.",
                    "label": 1
                }
            ]
        },
        "clip_2": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And this is actually based on work that appeared a few years ago.",
                    "label": 0
                },
                {
                    "sent": "Now at the end of 2006.",
                    "label": 0
                },
                {
                    "sent": "This is a paper that showed up in nature medicine and what they said what they claimed in this paper was that they figured out a really great thing specifically starting with cell lines.",
                    "label": 1
                },
                {
                    "sent": "They figured out how to come up with genomic signatures of sensitivity to a whole bunch of drugs.",
                    "label": 0
                },
                {
                    "sent": "So here's how this worked.",
                    "label": 0
                },
                {
                    "sent": "They're not just working with any panel of cell lines, they're working with the NCI 60 in the NCI 60, as was alluded to in the last talk, is a very special thing.",
                    "label": 0
                },
                {
                    "sent": "One reason it's very special.",
                    "label": 0
                },
                {
                    "sent": "Is that it's a standard panel maintained by the National Cancer Institute, and what that means is that if you've got a new chemotherapeutic, that agent will be sent to the National Cancer Institute and they will test it for efficacy against this panel of 60 cell lines, and that that information about which drugs are most effective against with cells.",
                    "label": 0
                },
                {
                    "sent": "That's public data, you can go and you can download it, and you can download this information for every single chemotherapeutic now available.",
                    "label": 0
                },
                {
                    "sent": "So if you can figure out how to leverage that information, that's potentially way to use.",
                    "label": 0
                },
                {
                    "sent": "Or choose the best single drug that's out there for a given patient.",
                    "label": 1
                },
                {
                    "sent": "So what they said was they said OK for using the NCI 60.",
                    "label": 0
                },
                {
                    "sent": "Let's start with the drug of interest, like docetaxel.",
                    "label": 0
                },
                {
                    "sent": "Let's pick the send most sensitive and most resistant cell lines.",
                    "label": 0
                },
                {
                    "sent": "OK, those are our extremes.",
                    "label": 0
                },
                {
                    "sent": "Let's take array profiles of those cell lines.",
                    "label": 0
                },
                {
                    "sent": "OK, fine, let US contrast them and identify the genes that are most different between Group One and Group 2.",
                    "label": 0
                },
                {
                    "sent": "These jeans will comprise elements of our sensitivity signature.",
                    "label": 0
                },
                {
                    "sent": "And then they say let's different model to come up with this sensitivity.",
                    "label": 0
                },
                {
                    "sent": "Signature Ann.",
                    "label": 0
                },
                {
                    "sent": "For doing this they use.",
                    "label": 0
                },
                {
                    "sent": "Meta genes, which sounds really cool, but to mathematicians we otherwise noted no.",
                    "label": 0
                },
                {
                    "sent": "It is principle components and I'm going to use that terminology and they're going to say OK.",
                    "label": 0
                },
                {
                    "sent": "Using these metagenes, let's try to fit the fit that at the cell lines and predict on clinical samples.",
                    "label": 0
                },
                {
                    "sent": "And they tried this with a whole bunch of public datasets using seven commonly use ages.",
                    "label": 0
                },
                {
                    "sent": "They reported great results and I know this was really splashy because within two weeks of this paper appearing we had three different groups of MD Anderson coming to us in bioinformatics and saying we want to do this.",
                    "label": 0
                },
                {
                    "sent": "Help us do it, and being helpful bioinformaticians, we said.",
                    "label": 0
                },
                {
                    "sent": "Well.",
                    "label": 0
                },
                {
                    "sent": "Sure, we'd love to do that, and in particular, since all of the data involved is public, we should be able to go out and figure out how to do it ourselves and generalize it to other trials.",
                    "label": 0
                },
                {
                    "sent": "OK, so let's let's try that and we decided to try that.",
                    "label": 0
                },
                {
                    "sent": "Starting with those attacks.",
                    "label": 0
                },
                {
                    "sent": "So we starting with the most sensitive and most resistant cell lines.",
                    "label": 0
                },
                {
                    "sent": "In this case, we're going to be using you 95 a raise for the NCI 60 these arrays were run in triplicate, so we've got 3 for each and when we did this and we.",
                    "label": 0
                }
            ]
        },
        "clip_3": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Tried to fit the training data.",
                    "label": 1
                },
                {
                    "sent": "Here is a plot of the first 2 principal components of these things and what you can see.",
                    "label": 0
                },
                {
                    "sent": "Not too surprisingly is that you have some pretty clear separation between all the resistant ones at the left and all the sensitive ones at the right.",
                    "label": 0
                },
                {
                    "sent": "This little triangle of three things.",
                    "label": 0
                },
                {
                    "sent": "Those are three replicates in the same cell line, so that's sort of what we expect to see now.",
                    "label": 0
                },
                {
                    "sent": "This separation should not surprise you.",
                    "label": 0
                },
                {
                    "sent": "This is the training set we have picked the genes specifically to achieve this separation.",
                    "label": 0
                },
                {
                    "sent": "What we now want to see is we now want to say clinical samples project it into this same space.",
                    "label": 0
                },
                {
                    "sent": "ANSI, this separation so that we can use it ourselves.",
                    "label": 0
                },
                {
                    "sent": "So we took the predicted the actual patient information and we projected.",
                    "label": 0
                }
            ]
        },
        "clip_4": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Into this space.",
                    "label": 0
                },
                {
                    "sent": "And we did not see the separation that we were really hoping and expecting to see.",
                    "label": 0
                },
                {
                    "sent": "So of course this led to the natural question of did we do something wrong?",
                    "label": 1
                },
                {
                    "sent": "And this is of course without.",
                    "label": 0
                },
                {
                    "sent": "Now we're going to start to reconstruct exactly what was done, and to do this, we began by saying, OK, well, OK. What were the signatures or the specific genes that they used for the individual drugs?",
                    "label": 0
                },
                {
                    "sent": "And this is actually somewhat easy because in the supplementary material to their paper they included here are the lists for each drug of all the Affymetrix probe set ID's that are involved in all the genes that are involved.",
                    "label": 0
                },
                {
                    "sent": "And into the paper they also gave some explanations about.",
                    "label": 0
                },
                {
                    "sent": "Here are some genes that make sense in the context of this drug, because it explains the biology and so on like that.",
                    "label": 0
                },
                {
                    "sent": "So OK, so we decided to pick one of the drugs and we started with five fluorouracil.",
                    "label": 0
                },
                {
                    "sent": "And what we?",
                    "label": 0
                }
            ]
        },
        "clip_5": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "I want to be able to do with this is we want to be able to construct a heat map that looks like this.",
                    "label": 0
                },
                {
                    "sent": "This is a heat map that actually showed up in the paper.",
                    "label": 0
                },
                {
                    "sent": "This is up the 45 genes that they picked out for five fluorouracil and one of the things that you can see is this Plaid pattern.",
                    "label": 0
                },
                {
                    "sent": "Because everyone of the 45 genes has a pattern that we like with another resistor high in one group and low in the other or low then high so OK, extreme separation, that's what we expect.",
                    "label": 0
                },
                {
                    "sent": "That's what we want in the cell lines so well, how they pick these?",
                    "label": 0
                },
                {
                    "sent": "Well they pick these using 2 sample T tests and I'm a PhD level statistician, so I figured out how to do 2 sample T test by this point.",
                    "label": 0
                }
            ]
        },
        "clip_6": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So we tried it ourselves, so here's our best 45 using T test so OK great and then we said, alright, let's take the list of Affymetrix probes that ideas for their 45 and taken.",
                    "label": 0
                }
            ]
        },
        "clip_7": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "That heat map and.",
                    "label": 0
                },
                {
                    "sent": "We didn't see again what we were expecting to see, so we then decided to try something which we've learned to unfortunately do.",
                    "label": 0
                },
                {
                    "sent": "Every once in awhile, which has been just a bit paranoid about the data and what we did then was.",
                    "label": 0
                },
                {
                    "sent": "We took our list and there's an we.",
                    "label": 0
                }
            ]
        },
        "clip_8": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Put them side by side so there's their list and there's ours.",
                    "label": 1
                },
                {
                    "sent": "Does anybody notice a pattern here?",
                    "label": 0
                },
                {
                    "sent": "What we have here is indeed an off by one indexing error.",
                    "label": 0
                },
                {
                    "sent": "This is true for all of the genes in this signature.",
                    "label": 0
                },
                {
                    "sent": "Now, what does that say to you about whether or not certain genes making sense in terms of the biology really holds when they're referencing a set of genes that actually isn't involved?",
                    "label": 0
                },
                {
                    "sent": "So now, of course, this is just one drug.",
                    "label": 0
                },
                {
                    "sent": "They looked at 7, so there's six others.",
                    "label": 0
                },
                {
                    "sent": "So what we decided to do for these six others, we basically took their reported at the IDs, move down one.",
                    "label": 0
                },
                {
                    "sent": "An looked at the P values to see if they were really small.",
                    "label": 0
                }
            ]
        },
        "clip_9": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So let's see.",
                    "label": 0
                },
                {
                    "sent": "Well, topotecan.",
                    "label": 0
                },
                {
                    "sent": "Yet they're all off by one etoposide off by one adriamycin, mostly off by 1.",
                    "label": 0
                },
                {
                    "sent": "There's a few.",
                    "label": 0
                },
                {
                    "sent": "We can't explain paclitaxel, mostly off by one docetaxel, mostly off by one and cytoxan.",
                    "label": 0
                },
                {
                    "sent": "We have no earthly idea what they did with this drug.",
                    "label": 0
                },
                {
                    "sent": "So, OK, fine, we've got this, and we know that that's one problem.",
                    "label": 0
                },
                {
                    "sent": "Now, how is it that this problem could arise?",
                    "label": 0
                },
                {
                    "sent": "And to answer that one, we went in and we looked at the software that they were using, and as a side note, if you want to read documentation on how this software works.",
                    "label": 0
                },
                {
                    "sent": "You should go to our website because I wrote it because we couldn't find any.",
                    "label": 0
                }
            ]
        },
        "clip_10": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And one of the things that we noted was that their software, in order to work, required two input files.",
                    "label": 1
                },
                {
                    "sent": "The first input file is the quantification matrix genes by samples, and this matrix needs a header row where the header is either 0, one or two to indicate that this is a training sample.",
                    "label": 1
                },
                {
                    "sent": "Sensitive training, sample resistant, or a test sample whose outcome we don't know.",
                    "label": 1
                },
                {
                    "sent": "That's the first input, the qualification matrix.",
                    "label": 1
                },
                {
                    "sent": "The second input is a list of Gene IDs.",
                    "label": 0
                },
                {
                    "sent": "Gene names in the same order as in the quantification matrix.",
                    "label": 1
                },
                {
                    "sent": "What for their software to work correctly?",
                    "label": 1
                },
                {
                    "sent": "This second input must not have a header row, so if you start with an Excel file and you copy and you paste an, you've got to take title at the top.",
                    "label": 0
                },
                {
                    "sent": "It says gene name.",
                    "label": 0
                },
                {
                    "sent": "Guess what happens, you will get an off by one indexing here, and if you run this through your software, we tried this with those attacks and we perfectly matched the heat Maps and we also got some of these offset jeans, so we know that works.",
                    "label": 0
                },
                {
                    "sent": "But again, that's one drug docetaxel out of seven.",
                    "label": 0
                },
                {
                    "sent": "So what happens?",
                    "label": 0
                }
            ]
        },
        "clip_11": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "The other six.",
                    "label": 0
                },
                {
                    "sent": "Well, let's take a look.",
                    "label": 0
                },
                {
                    "sent": "OK, Topotecan, we can perfectly match the heat Maps.",
                    "label": 0
                },
                {
                    "sent": "We know what cell lines are involved.",
                    "label": 0
                },
                {
                    "sent": "We know what jeans they should be producing.",
                    "label": 0
                },
                {
                    "sent": "OK, fine, Adrian myosin perfectly total site, perfect five fut perf.",
                    "label": 0
                },
                {
                    "sent": "Paclitaxel.",
                    "label": 0
                },
                {
                    "sent": "Well, they mislabeled to cyclophosphamide in the paper, but OK. Cyclophosphamide, we still have no earthly idea what they did with this.",
                    "label": 1
                },
                {
                    "sent": "So OK, there's things that we can perfectly match the heat Maps for six of the seven drugs.",
                    "label": 0
                },
                {
                    "sent": "We understand what they did now.",
                    "label": 0
                },
                {
                    "sent": "Actually before we go on, I should note that this should actually bother you.",
                    "label": 0
                },
                {
                    "sent": "And the reason it should bother you is that we've perfectly matched the heat Maps for six of the seven drugs, but we managed to perfectly match the gene lists for only three for four of the drugs.",
                    "label": 0
                },
                {
                    "sent": "There are included other genes that we can't explain just yet.",
                    "label": 0
                }
            ]
        },
        "clip_12": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "They are outliers and we'll come back to those because before we get there we also noticed in using their software that something that was more important to us, which was that their software also gave predictions and this is the clinical thing that we're really interested in.",
                    "label": 1
                },
                {
                    "sent": "We want to know is this patient going to be sensitive or not?",
                    "label": 0
                },
                {
                    "sent": "So we wanted to see can we get good predictions out of this software and the way we're going to check this?",
                    "label": 1
                },
                {
                    "sent": "Well, there's a bit of a problem in the paper.",
                    "label": 0
                },
                {
                    "sent": "Doesn't say for the fitting datasets that they fit this patient turned out to be sensitive.",
                    "label": 0
                },
                {
                    "sent": "This one resistant.",
                    "label": 0
                },
                {
                    "sent": "Now they just gave us an overall.",
                    "label": 0
                },
                {
                    "sent": "Rate of accuracy.",
                    "label": 0
                },
                {
                    "sent": "OK, so that they got.",
                    "label": 0
                },
                {
                    "sent": "If they've got 24 patients they got 22 of them right?",
                    "label": 0
                },
                {
                    "sent": "OK, fine, so we're going to say that we understand the classification algorithm or this thing well enough to use it.",
                    "label": 0
                },
                {
                    "sent": "If we can get accuracies at least as good as the ones that they report, OK, that's our bar.",
                    "label": 0
                },
                {
                    "sent": "So that of course brings.",
                    "label": 0
                }
            ]
        },
        "clip_13": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "The next question, which is just how good are the accuracy rates that they obtain, so we're going to look at this in the context of docetaxel and this top plot is a figure from the paper, and you can see the scores for the sensitive patients, and they are mostly low with blue squares.",
                    "label": 0
                },
                {
                    "sent": "That's good, resistant ones, are high, and they've got red triangles, and that's good, and I have a question here.",
                    "label": 0
                },
                {
                    "sent": "I have an analysis question for the audience.",
                    "label": 0
                },
                {
                    "sent": "The analysis question is how many blue squares are there?",
                    "label": 0
                },
                {
                    "sent": "13 that is correct.",
                    "label": 0
                },
                {
                    "sent": "We have up there in the top pot.",
                    "label": 0
                },
                {
                    "sent": "13 sensitive samples, an 11 resistant ones.",
                    "label": 0
                },
                {
                    "sent": "Now there's a second panel on this page right here.",
                    "label": 0
                },
                {
                    "sent": "The thing is, this panel doesn't come from this paper.",
                    "label": 0
                },
                {
                    "sent": "This panel comes from a paper by Chang at all.",
                    "label": 0
                },
                {
                    "sent": "They are the ones that actually introduced the test set being analyzed here.",
                    "label": 0
                },
                {
                    "sent": "And according to Chang at all, they thought that they had 11 sensitive and 13 resistant.",
                    "label": 0
                },
                {
                    "sent": "So 1311 or 11 and 13.",
                    "label": 0
                },
                {
                    "sent": "That may be a problem, so we decided to take a look at a different drug, namely adriamycin, and for those of you who are real math with.",
                    "label": 0
                }
            ]
        },
        "clip_14": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Is here how many red triangles are there OK for those who aren't quite that ambitious?",
                    "label": 0
                },
                {
                    "sent": "Are there more red triangles or blue squares?",
                    "label": 0
                },
                {
                    "sent": "Come on, this is not a trick question.",
                    "label": 0
                },
                {
                    "sent": "I hear red triangles or with both.",
                    "label": 0
                },
                {
                    "sent": "So basically we've got a whole bunch of patients that are resistant to therapy.",
                    "label": 0
                },
                {
                    "sent": "The problem is, in this case the underlying data set that's applied this thing.",
                    "label": 0
                },
                {
                    "sent": "This was from a paper on childhood leukemia.",
                    "label": 0
                },
                {
                    "sent": "The reason this is a problem is that childhood leukemia is a disease for which we've actually got a pretty good cure rate, around 80%, and what that means is that if we've got a drug to which most of the patients are resistant, we wouldn't be using it.",
                    "label": 0
                },
                {
                    "sent": "And indeed, if we go back to the original paper that submitted it, they thought that most of their patients were sensitive.",
                    "label": 0
                },
                {
                    "sent": "So what do we think is going on?",
                    "label": 0
                },
                {
                    "sent": "We think that for zero and one they swapped the interpretation in feeding it into the data and they didn't realize what they were doing.",
                    "label": 0
                },
                {
                    "sent": "Now what does this mean?",
                    "label": 0
                },
                {
                    "sent": "Clinically, it means that what well, they're going to use that signature, and they're going to administer adriamycin just to the patients who will derive no benefit from it.",
                    "label": 0
                },
                {
                    "sent": "This is poor clinical practice, so we don't think this is a good idea.",
                    "label": 0
                },
                {
                    "sent": "So given this, there is the question of OK if they're mixing things up this badly, how is it that they're getting good predictions in the 1st place?",
                    "label": 0
                },
                {
                    "sent": "And actually, this leads back to one of the things that we passed on just.",
                    "label": 0
                }
            ]
        },
        "clip_15": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "A few minutes ago, which is that there were some other jeans, and in particular for docetaxel, there were 50 jeans.",
                    "label": 1
                },
                {
                    "sent": "If we take our list of docetaxel, and we do this off by 1 trick, we match 31.",
                    "label": 0
                },
                {
                    "sent": "That leaves 19 of these.",
                    "label": 0
                },
                {
                    "sent": "19.",
                    "label": 0
                },
                {
                    "sent": "There's the question of where can they come from?",
                    "label": 0
                },
                {
                    "sent": "Well, if you go back to the initial paper by Chang at all, that supply the test set, they say if you want to separate our resistance from our sensitives, here's a list of 92 genes that will do the job.",
                    "label": 1
                },
                {
                    "sent": "So we said, OK, let's take a look at the 19.",
                    "label": 0
                },
                {
                    "sent": "We can't match and compare them with the 90 two they report.",
                    "label": 0
                },
                {
                    "sent": "And we find out that there is an overlap of 14 jeans.",
                    "label": 0
                },
                {
                    "sent": "There you go, there are entries 7 through 20 in this list, one contiguous block.",
                    "label": 0
                },
                {
                    "sent": "I think we have some statisticians in the audience.",
                    "label": 0
                },
                {
                    "sent": "So quick question.",
                    "label": 0
                },
                {
                    "sent": "If I pick 14 items at random from a list with 92 in it, how often do they all appear right next to each other?",
                    "label": 0
                },
                {
                    "sent": "The P value is small.",
                    "label": 0
                },
                {
                    "sent": "You can get published with this one.",
                    "label": 0
                },
                {
                    "sent": "OK, now first this still leaves 5.",
                    "label": 0
                },
                {
                    "sent": "One of the other five.",
                    "label": 0
                },
                {
                    "sent": "Will the RCC one IRCC for Herb, two, BCL 211 and two or three.",
                    "label": 0
                },
                {
                    "sent": "The thing that the common theme of these five.",
                    "label": 0
                },
                {
                    "sent": "Is that these are the genes mentioned by name in the paper to explain why the signature works so for the docetaxel signature we have the genes that work to split the test set, the jeans that work to split the training set and the jeans that are there to explain why it works.",
                    "label": 0
                },
                {
                    "sent": "And there is no overlap between these three.",
                    "label": 0
                },
                {
                    "sent": "We thought this was somewhat disturbing, so we wrote a letter to Nature medicine.",
                    "label": 0
                }
            ]
        },
        "clip_16": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "One of the things about this being a talk on reproducible research is that you don't have to take my word for it, which means that you can go to nature medicine.",
                    "label": 1
                },
                {
                    "sent": "You can read the paper.",
                    "label": 0
                },
                {
                    "sent": "You can also read our reports which contain all of our code.",
                    "label": 0
                },
                {
                    "sent": "You can run it through our and you will get the same numbers we do.",
                    "label": 0
                },
                {
                    "sent": "As a side note, for data compression are note to nature.",
                    "label": 0
                },
                {
                    "sent": "Medicine is 700 words.",
                    "label": 0
                },
                {
                    "sent": "There's 140 pages of supplementary material for those 700 words there, so there's a bit of a compression there, so that was fun, and so all the data is there.",
                    "label": 0
                },
                {
                    "sent": "And then of course we wanted to see OK is their response.",
                    "label": 0
                },
                {
                    "sent": "So they say Oh well, whoops, we got it wrong, will fix it next time.",
                    "label": 0
                },
                {
                    "sent": "Won't know that wasn't quite the response.",
                    "label": 0
                }
            ]
        },
        "clip_17": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "The response was well, unfortunately, the analysis of Baggerly and Coombes is deeply flawed, and a bunch other errors.",
                    "label": 0
                },
                {
                    "sent": "Well First off, for Adrian myosin, the labels.",
                    "label": 0
                },
                {
                    "sent": "This is the one where they have a lot of red triangles.",
                    "label": 0
                },
                {
                    "sent": "The labels are actually correct, and we've posted details on our website to illustrate this and they must be wrong because we've gotten this approach to work again and in their rebuttal, they note that they've done it twice in new papers with editorials and things like that, so we must have screwed up and well, given the timing.",
                    "label": 1
                },
                {
                    "sent": "I'm not going to be able to go through.",
                    "label": 0
                },
                {
                    "sent": "All of these, but I want to look at some of the data for one or two of these.",
                    "label": 0
                },
                {
                    "sent": "Just just illustrate what might be going on.",
                    "label": 0
                },
                {
                    "sent": "So let's start with Adrian myosin for Adrian myosin.",
                    "label": 0
                },
                {
                    "sent": "They say they've got the labels correct on their website, so we went to their web page and we said what's there?",
                    "label": 1
                },
                {
                    "sent": "Well, actually, when we went there, we saw that there were there's a table of qualifications for 144 samples, 22 for training cell lines, and 122 for test.",
                    "label": 0
                },
                {
                    "sent": "These are the patient ones for which they're making predictions, and we said, well, maybe we can find something that separates the responders from the non responders.",
                    "label": 0
                },
                {
                    "sent": "So we decided, let's try to cluster it, and as a prelude to that.",
                    "label": 0
                },
                {
                    "sent": "Let's just check the correlations between individual pairs of elements and.",
                    "label": 0
                }
            ]
        },
        "clip_18": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "I'm going to show you now is a plot of all the really high correlations we see in this matrix of 144 samples.",
                    "label": 0
                },
                {
                    "sent": "Here's the submatrix corresponding to the training data, the cell lines.",
                    "label": 0
                },
                {
                    "sent": "And here's the test data.",
                    "label": 0
                },
                {
                    "sent": "Now the red line on the main diagonal we expected samples are indeed highly correlated with themselves.",
                    "label": 0
                },
                {
                    "sent": "That's good.",
                    "label": 0
                },
                {
                    "sent": "However, we didn't expect these red dots off the main diagonal.",
                    "label": 0
                },
                {
                    "sent": "What's going on?",
                    "label": 0
                },
                {
                    "sent": "Well, turns out they had 122 test samples.",
                    "label": 0
                },
                {
                    "sent": "But the 122 are not all distinct.",
                    "label": 0
                },
                {
                    "sent": "There are some samples that they have reused 2, three, or even four times, and there's a sample right about here which has been reused four times, which has been labeled as resistant three times out of four.",
                    "label": 0
                },
                {
                    "sent": "Now that's the same sample, so we're pretty pretty convinced that the labels are not all correct even now.",
                    "label": 0
                },
                {
                    "sent": "So we sent a further note to Nature Medicine about this and nature medicine forwarded this onto the authors, and then they got back to us and said, well, they'll adjust it, so we see no need to publish your note.",
                    "label": 0
                },
                {
                    "sent": "OK, fine.",
                    "label": 0
                },
                {
                    "sent": "And indeed.",
                    "label": 0
                }
            ]
        },
        "clip_19": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "What they said later in August of 08 was that they had redone the analysis using only the 95 unique samples, and again gotten great results.",
                    "label": 1
                },
                {
                    "sent": "Now, for those of you who are listening to me carefully before you will recall that, I said that there were actually 84 distinct samples.",
                    "label": 0
                },
                {
                    "sent": "So hearing that there were 95 was a bit of a surprise to us.",
                    "label": 0
                },
                {
                    "sent": "So, OK, but fine.",
                    "label": 0
                },
                {
                    "sent": "And what they do now.",
                    "label": 0
                },
                {
                    "sent": "Well, when they corrected this in August, oh wait, they actually took down the qualifications and they just put up a list of the 95 Geo ideas of the arrays involved.",
                    "label": 0
                },
                {
                    "sent": "So let me show you the 1st 20 of the 90s.",
                    "label": 0
                }
            ]
        },
        "clip_20": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "They now list.",
                    "label": 0
                },
                {
                    "sent": "And I've highlighted a few of them because that seems twice that seems twice this ones whose twice and labeled both ways.",
                    "label": 0
                },
                {
                    "sent": "So actually of the 95 which is.",
                    "label": 0
                },
                {
                    "sent": "This is the second correction, by the way, 15 are in duplicate of those, 1566 are labeled both ways, and Furthermore, since they've actually notes now, told us the Geo ideas of the individual arrays, we can actually go back and figure out what the initial submitters thought they were in terms of resistant or sensitive.",
                    "label": 0
                },
                {
                    "sent": "So the group that the Duke Group says that 61 or resistant.",
                    "label": 0
                },
                {
                    "sent": "13 or sensitive and six.",
                    "label": 0
                },
                {
                    "sent": "We don't know.",
                    "label": 0
                },
                {
                    "sent": "The people submitting the data set up at 22 or resistant 48 were sensitive and tend they labeled as intermediate.",
                    "label": 0
                },
                {
                    "sent": "They didn't classify him.",
                    "label": 0
                },
                {
                    "sent": "So for Adriamycin, we're not convinced this works well alright.",
                    "label": 0
                },
                {
                    "sent": "There's still other things that they put out there.",
                    "label": 0
                },
                {
                    "sent": "There's other paper.",
                    "label": 0
                }
            ]
        },
        "clip_21": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "With editorial so let me show you one of those.",
                    "label": 0
                },
                {
                    "sent": "This is a paper that showed up in the Journal of Clinical Oncology by Sue at all and in this paper they extended the approach to deal with two new drugs, cisplatin and pemetrexed.",
                    "label": 0
                },
                {
                    "sent": "It these are important in treating lung cancer and one of the things that they thought was really neat was they said OK, we actually don't like the NCI 60 for all drugs so we're going to shift to a different set of cell lines and these cell lines were profiled on Matthew 133 arrays and one of the things that they did using this was they came up with the signature versus platinum versus platinum.",
                    "label": 0
                },
                {
                    "sent": "They pointed out something important specifically that the signature they found contained.",
                    "label": 0
                },
                {
                    "sent": "GRCC 1 ERC C4 in DNA repair genes.",
                    "label": 1
                },
                {
                    "sent": "That's important because there have been several papers in the New England Journal saying these are related to how you treat lung cancer.",
                    "label": 0
                },
                {
                    "sent": "So that's really cool.",
                    "label": 0
                },
                {
                    "sent": "So what we do?",
                    "label": 0
                },
                {
                    "sent": "Well, we took the data and we said alright, let's try to see if we could match the heat map so we know the cell lines and the genes involved and after with some work and that's another compression thing there.",
                    "label": 0
                },
                {
                    "sent": "We did manage to exactly match the heat Maps and for cisplatin after we exactly match the heat map, we took a look at the genes involved an we discovered that we could match.",
                    "label": 0
                },
                {
                    "sent": "41 of the 45 genes they report after accounting for this off by 1 error that still there, there's four that we can't match at all.",
                    "label": 0
                },
                {
                    "sent": "Do I have any guesses from the audience as to the identities of those four?",
                    "label": 0
                },
                {
                    "sent": "The form that we.",
                    "label": 0
                }
            ]
        },
        "clip_22": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Cannot match RERC C1 ERC C4 RCC one again.",
                    "label": 0
                },
                {
                    "sent": "In fact an up these for the last two are special because as it turns out those two aren't on the 133 arrays there on the 133 B, so two of their best jeans they haven't measured yet.",
                    "label": 1
                },
                {
                    "sent": "But hey, who needs to conduct experiments?",
                    "label": 0
                },
                {
                    "sent": "If you know the answer this is a wonderful finding.",
                    "label": 0
                },
                {
                    "sent": "OK, great so we were disturbed by this.",
                    "label": 0
                },
                {
                    "sent": "As a side note, we submitted a correction for this one to JCO and they sent us a note back saying we're sorry we can't publish this and we said OK fine and over the next few years what?",
                    "label": 0
                }
            ]
        },
        "clip_23": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "What went on from there is that there were other papers that kept on coming 070809 but middle of last year we learn something new that sort of disturbed us and what we learned middle of last year.",
                    "label": 0
                }
            ]
        },
        "clip_24": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Wasn't it already started running clinical trials using these rules to allocate patients to treatment arms?",
                    "label": 0
                },
                {
                    "sent": "They're doing this using pemetrexed and cisplatin, pemetrexed and Viorel, being docetaxel, doxorubicin and for several of these drugs.",
                    "label": 0
                },
                {
                    "sent": "These are in cases where in the posted signatures they've gotten the sensitive and resistant labels reversed so we think this is a problem so we wrote up a paper on this.",
                    "label": 0
                },
                {
                    "sent": "We first circulated it to a biological Journal and got the comment back that we're sorry this story.",
                    "label": 0
                },
                {
                    "sent": "The story seems to negative.",
                    "label": 0
                },
                {
                    "sent": "Can you fix that?",
                    "label": 0
                },
                {
                    "sent": "At which point we said, well, we.",
                    "label": 0
                }
            ]
        },
        "clip_25": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Probably count, so we sent it off the hours of applied statistics on the 1st of September, it was accepted and published online by the 14th, at which point was covered by the press.",
                    "label": 1
                },
                {
                    "sent": "Duke starts an internal investigation and suspended the trials pending the outcome of the investigation.",
                    "label": 0
                },
                {
                    "sent": "That was October of last year.",
                    "label": 0
                },
                {
                    "sent": "So what?",
                    "label": 0
                }
            ]
        },
        "clip_26": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Next as of the end of January of this year.",
                    "label": 0
                },
                {
                    "sent": "Duke decided to restart the trials, and in particular they said that their investigation, which was now concluded, had strengthened their confidence in this evolving approach to personalized cancer treatment.",
                    "label": 1
                },
                {
                    "sent": "Now we were not really pleased by this and the main.",
                    "label": 0
                }
            ]
        },
        "clip_27": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Reason we were not really pleased is that we ask them.",
                    "label": 0
                },
                {
                    "sent": "Well, OK, we don't understand that it can.",
                    "label": 0
                },
                {
                    "sent": "You show us the data and stuff that you used to come to reach this conclusion and they said, well, no.",
                    "label": 0
                },
                {
                    "sent": "While their reviewers that conducted these things approved are sharing our report with the National Cancer Institute, we consider it a confidential document.",
                    "label": 1
                },
                {
                    "sent": "So now you can't see it.",
                    "label": 0
                },
                {
                    "sent": "Which disturbed us and as a side note there.",
                    "label": 0
                }
            ]
        },
        "clip_28": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Just one more thing.",
                    "label": 0
                },
                {
                    "sent": "Which is that this investigation took place between October and January.",
                    "label": 0
                },
                {
                    "sent": "Well, as it happens in November, something new happened.",
                    "label": 0
                },
                {
                    "sent": "In November, they posted data.",
                    "label": 1
                },
                {
                    "sent": "They posted new data for one paper dealing with cisplatin and pemetrexed.",
                    "label": 1
                },
                {
                    "sent": "These are two of the drugs.",
                    "label": 0
                },
                {
                    "sent": "They're using clinical trials.",
                    "label": 0
                },
                {
                    "sent": "An in this data, they said, here are the 59 samples that were using as a validation set to show that this works.",
                    "label": 0
                },
                {
                    "sent": "These 59 samples are a subset of this one Geo data set and we're using it to make predictions.",
                    "label": 0
                },
                {
                    "sent": "So we said, OK, cool, we see these 59 samples.",
                    "label": 0
                },
                {
                    "sent": "We've got the ovarian ones.",
                    "label": 0
                },
                {
                    "sent": "Let's go in and take a look at them.",
                    "label": 0
                },
                {
                    "sent": "So the very first thing we did with these 59 samples we said let's go back to the Geo data set and see if we can match them up.",
                    "label": 0
                }
            ]
        },
        "clip_29": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And when we did, here's what we found.",
                    "label": 0
                },
                {
                    "sent": "So what if the names matched up for all the for all the 59 samples we should see 59 red squares lying on this blue diagonal line.",
                    "label": 1
                },
                {
                    "sent": "How many red squares do you see lying on that blue diagonal line?",
                    "label": 0
                },
                {
                    "sent": "This is not a hard counting question.",
                    "label": 0
                },
                {
                    "sent": "None.",
                    "label": 1
                },
                {
                    "sent": "40 three of the samples they got the labels wrong for 16 they didn't get the labels wrong, or at least the problem is for these 16.",
                    "label": 0
                },
                {
                    "sent": "We can't tell the reason we can't tell us that for those 16, they've scrambled the gene labels so badly that we don't know what samples they correspond to.",
                    "label": 0
                },
                {
                    "sent": "What this means is that for their validation data set, every single sample is incorrect.",
                    "label": 0
                },
                {
                    "sent": "For two drugs they've been using in clinical trials for two years.",
                    "label": 0
                },
                {
                    "sent": "We think this is disturbing.",
                    "label": 0
                },
                {
                    "sent": "So what happened next?",
                    "label": 0
                },
                {
                    "sent": "We pointed this out at the end of January.",
                    "label": 0
                },
                {
                    "sent": "No response, so we then said can we do anything else and it occurred to us that they said, well, we won't show you the report, but the reviewers approved of us sending it to the NCI.",
                    "label": 0
                },
                {
                    "sent": "Now the NCI in the US is a federally funded institution and what that means is that they are subject to federal law specifically.",
                    "label": 0
                }
            ]
        },
        "clip_30": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "The Freedom of Information Act.",
                    "label": 0
                },
                {
                    "sent": "So in April we filed a request with the NCI to get the report under the Freedom of Information Act and at the start of May they redacted version of the report was indeed supplied and we looked at it.",
                    "label": 1
                },
                {
                    "sent": "We found a few things that were rather interesting in the report or weren't in the.",
                    "label": 0
                }
            ]
        },
        "clip_31": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Report the two main things that we found were the First off the review committee that went through this stuff.",
                    "label": 0
                },
                {
                    "sent": "The people have Valuated said by the way we couldn't figure out from the data that's been published how to do this.",
                    "label": 0
                },
                {
                    "sent": "The only way we got it is because there was extra information supplied to us and we really recommend that the investigators make that public.",
                    "label": 0
                },
                {
                    "sent": "So that's one thing.",
                    "label": 0
                },
                {
                    "sent": "The other thing that we found rather disturbing what wasn't there specifically?",
                    "label": 0
                },
                {
                    "sent": "This report makes no mention of those problems with cisplatin pemetrexed that I just told you about.",
                    "label": 0
                },
                {
                    "sent": "It's not there so we pointed this out in May and also in May.",
                    "label": 0
                },
                {
                    "sent": "We ask the National Cancer Institute what do you think about what's going on and well they said.",
                    "label": 0
                },
                {
                    "sent": "Let's look at the trials.",
                    "label": 0
                },
                {
                    "sent": "We actually don't fund those three clinical trials.",
                    "label": 0
                }
            ]
        },
        "clip_32": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "You found another one.",
                    "label": 0
                },
                {
                    "sent": "That's a phase three and actually based on that they re investigated the rationale and they yanked that signature from the phase three clinical trial in the middle of the trial.",
                    "label": 1
                },
                {
                    "sent": "That's mid may we said, OK, is there anything further that's going to happen with these with the three ongoing trials at Duke, nothing happened.",
                    "label": 0
                },
                {
                    "sent": "Nothing happened for two more months and then in mid July we found out something new that's a bit orthogonal from your normal status.",
                    "label": 0
                }
            ]
        },
        "clip_33": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "One of the puppies used to claim he was a Rhodes scholar.",
                    "label": 0
                },
                {
                    "sent": "The Rhodes Trust in Britain says no, no, he wasn't.",
                    "label": 0
                },
                {
                    "sent": "Indeed, it appears there was some CV fudging involved.",
                    "label": 0
                },
                {
                    "sent": "Now, what happened then was that I knew that there were a few statisticians have been talking about saying maybe we should write a letter or something.",
                    "label": 0
                },
                {
                    "sent": "So I emailed a few of them the day this came out and said, you know, if you want to write a letter, now is about the best time, so the following.",
                    "label": 0
                }
            ]
        },
        "clip_34": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Day three days later, there was a letter from 3133 Biostatisticians find a few that you like.",
                    "label": 0
                },
                {
                    "sent": "Cancer Letter comments that Dukes administrators have accomplished something monumental.",
                    "label": 0
                },
                {
                    "sent": "They triggered a public expression of outrage from Biostatisticians who cool.",
                    "label": 1
                },
                {
                    "sent": "But the fun thing about this letter was that it went to the newly appointed head of the National Cancer Institute, Harold Varmus, and to Duke and to the DoD and to the press.",
                    "label": 0
                },
                {
                    "sent": "So this one got some coverage.",
                    "label": 0
                },
                {
                    "sent": "So what happened?",
                    "label": 0
                }
            ]
        },
        "clip_35": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Duke suspended the trials.",
                    "label": 0
                },
                {
                    "sent": "This has since been covered just a bit in a few other outlets like NPR, Science, Nature and some other fly by night journals and a few other investigations are underway and there's actually a new Google Group devoted entirely to reproducible research and things like that.",
                    "label": 0
                },
                {
                    "sent": "But as we've been looking at this, there is a caveat that I think we should keep in mind, and that caveat is that unfortunately, some of these mistakes like the.",
                    "label": 0
                }
            ]
        },
        "clip_36": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "For one, we've seen them before.",
                    "label": 0
                },
                {
                    "sent": "This is not the only time we've seen some of these examples going back to 2002, 2003, 2005.",
                    "label": 0
                },
                {
                    "sent": "These types of errors have been around for a while.",
                    "label": 0
                },
                {
                    "sent": "This isn't egregious combination, but the problems are there, so some observation.",
                    "label": 0
                }
            ]
        },
        "clip_37": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Jones the most common mistakes are simple ones.",
                    "label": 1
                },
                {
                    "sent": "For example, in statistics.",
                    "label": 1
                },
                {
                    "sent": "The simplest one here for genomics is complete confounding of the experimental design.",
                    "label": 1
                },
                {
                    "sent": "Others involved mixing up sample labels, gene labels, things that are easy to do in Excel.",
                    "label": 0
                },
                {
                    "sent": "OK, those are easy to mistake.",
                    "label": 0
                },
                {
                    "sent": "Now the fun thing about simple mistakes is that if you see them, they're easy to fix.",
                    "label": 0
                },
                {
                    "sent": "But if the documentation is poor, you won't see them, so they will slip by because our intuition is no good.",
                    "label": 0
                },
                {
                    "sent": "And what that means is that if you go out to the literature.",
                    "label": 1
                },
                {
                    "sent": "We sort of suspect that the most simple mistakes are more common than we would like to admit.",
                    "label": 0
                },
                {
                    "sent": "Now what would we?",
                    "label": 0
                }
            ]
        },
        "clip_38": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Like to have happened.",
                    "label": 0
                },
                {
                    "sent": "Well for papers we've got a little thing of saying, here's some things we really would like to see in addition to data like this stuff at Geo, we'd really like some idea of if you're going to supply us with a table of quantifications, please label the columns.",
                    "label": 0
                },
                {
                    "sent": "Tell us which samples are which, and provide code so these are some other things, and these are recommendations for papers, but we think they should be actually absolute requirements before you start clinical trials.",
                    "label": 0
                },
                {
                    "sent": "Now do we.",
                    "label": 0
                },
                {
                    "sent": "As the phrase goes, walk the walk.",
                    "label": 0
                }
            ]
        },
        "clip_39": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Did we do well?",
                    "label": 0
                },
                {
                    "sent": "Partially in response to this.",
                    "label": 0
                },
                {
                    "sent": "About in early 2007, Kevin Coombs and I went into our our Department of Bioinformatics with MD Anderson.",
                    "label": 0
                },
                {
                    "sent": "We said guess what?",
                    "label": 0
                },
                {
                    "sent": "Henceforth we are announcing by Fiat that all reports that we write are now going to be written in S we've combination of are in LA Tech.",
                    "label": 1
                },
                {
                    "sent": "The fun thing about us we've is that you can take these reports.",
                    "label": 0
                },
                {
                    "sent": "You can run them through our.",
                    "label": 0
                },
                {
                    "sent": "Somebody else can run them through our and get the same numbers.",
                    "label": 0
                },
                {
                    "sent": "As a side note, most of our reports now go are written by stat analyst.",
                    "label": 0
                },
                {
                    "sent": "Faculty member teams.",
                    "label": 0
                },
                {
                    "sent": "The analyst writes the report submitted to the faculty member of the Faculty member proofread it reruns the code if necessary, and only after the second approval does it go off to the biological Pi.",
                    "label": 0
                },
                {
                    "sent": "This is actually helped our reproducibility quite a bit.",
                    "label": 0
                },
                {
                    "sent": "So actually if you ask us what we did in any report, going back for about 3 years now, we can tell you exactly we find that useful, But the buzz phrase in all of this is reproducible research Now, so I've given you some observations and I've told you lessons that I really want you to drive from it.",
                    "label": 1
                },
                {
                    "sent": "So I have one last slide and that is to ignore.",
                    "label": 0
                }
            ]
        },
        "clip_40": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Lidge some folks so Kevin Coombs is my primary coauthor in all these things.",
                    "label": 0
                },
                {
                    "sent": "Some other folks at MD Anderson, the various groups that provided money at MD Anderson.",
                    "label": 0
                },
                {
                    "sent": "And of course, if you want to read more, you can go to the annals of Applied Statistics and you can read the paper.",
                    "label": 1
                },
                {
                    "sent": "You can look at the code.",
                    "label": 0
                },
                {
                    "sent": "Even better, you can cite the paper 'cause that'll make me famous and my mom happy and she can buy me more micro ties for Christmas and I have one last acknowledgement wishes to you.",
                    "label": 0
                },
                {
                    "sent": "My kind audience for bearing with me for the past half hour.",
                    "label": 0
                },
                {
                    "sent": "And that's what I got.",
                    "label": 0
                },
                {
                    "sent": "Thank you.",
                    "label": 0
                },
                {
                    "sent": "Thank you very much.",
                    "label": 0
                },
                {
                    "sent": "There must be questions.",
                    "label": 0
                },
                {
                    "sent": "OK, for things that would be appropriate for going to clinical trials.",
                    "label": 0
                },
                {
                    "sent": "First off, the rule needs to be specified sufficiently precisely that an independent person outside of that group can rerun it and get the same numbers.",
                    "label": 0
                },
                {
                    "sent": "Since lots of clinical trials are on institutions with their own Institutional Review Board, it should be specified clearly enough for a representative of that Institutional Review Board to run it and get the same numbers.",
                    "label": 0
                },
                {
                    "sent": "This will typically be a biostatistician at the Associated Cancer Center.",
                    "label": 0
                },
                {
                    "sent": "They should be able to do that in going from one going from.",
                    "label": 0
                },
                {
                    "sent": "In particular cell lines, etc.",
                    "label": 0
                },
                {
                    "sent": "We would really like to see this replicated in an independent data set, at least one beyond the one that you've got.",
                    "label": 0
                },
                {
                    "sent": "The other one thing that we toss in that, just as a caveat to guard against some of the confounding issues that we've talked about, in particular for any finding that we that we look at that says, wow, this is wonderful.",
                    "label": 0
                },
                {
                    "sent": "Our first reaction at this point is OK. What type of batch effect did we miss?",
                    "label": 0
                },
                {
                    "sent": "So we tend to take the jeans that are most interesting.",
                    "label": 0
                },
                {
                    "sent": "And before we use them, we plop them as a function of run date.",
                    "label": 0
                },
                {
                    "sent": "Simply to see, do we see obvious batch effects that might cause us to be curious, but those are the very quick and dirty things that I can think of.",
                    "label": 0
                },
                {
                    "sent": "There's a more extensive list, but that will take longer to explain, OK?",
                    "label": 0
                },
                {
                    "sent": "This is actually made a comment.",
                    "label": 0
                },
                {
                    "sent": "We saw similar situation in in less.",
                    "label": 0
                },
                {
                    "sent": "A critical issue like Self Line and things to experiment like that that we use using meta analysis from things coming from the geodatabase.",
                    "label": 0
                },
                {
                    "sent": "Unfortunately one of the main problem I think is related to the fact that the vast majority of the reviewer of the biological Journal will trust all the part related to the micro analysis and we completely skip it simply they.",
                    "label": 0
                },
                {
                    "sent": "Take the final results and they evaluate out those fits to the evidence that are coming from the wet lab, and this is actually the problem.",
                    "label": 0
                },
                {
                    "sent": "When I review some of these microarray paper normally the first time I have always to ask for extra information, but are never enough in the in the methods.",
                    "label": 0
                },
                {
                    "sent": "But this is a general situation for everything that is handled by the biological reviewer.",
                    "label": 0
                },
                {
                    "sent": "Actually, that's a general problem that's not the whole problem, in part because.",
                    "label": 0
                },
                {
                    "sent": "There is no way that any individual reviewer could have caught all the problems that we talked about.",
                    "label": 0
                },
                {
                    "sent": "'cause that involves detailed examination of the raw data.",
                    "label": 0
                },
                {
                    "sent": "What we do ask right now when we when I'm reviewing papers for example is I look and say alright, do they tell me where the data is?",
                    "label": 0
                },
                {
                    "sent": "Do they give me a URL or something?",
                    "label": 0
                },
                {
                    "sent": "Do they tell me where I can find the code?",
                    "label": 0
                },
                {
                    "sent": "Are the links actually live?",
                    "label": 0
                },
                {
                    "sent": "Can I see it?",
                    "label": 0
                },
                {
                    "sent": "I don't go through and check it for accuracy at that time, so that's a bit of an issue.",
                    "label": 0
                },
                {
                    "sent": "We are actually in the process of talking to a large number.",
                    "label": 0
                },
                {
                    "sent": "Journal editors and funding agencies, even now to say guys we need to fix this.",
                    "label": 0
                },
                {
                    "sent": "So actually some of this is going on with the editors of the nature family 'cause they're not too happy that this showed up in nature medicine.",
                    "label": 0
                },
                {
                    "sent": "For some reason, they're saying, OK, we'd like to fix that.",
                    "label": 0
                },
                {
                    "sent": "How can we fix that?",
                    "label": 0
                },
                {
                    "sent": "One of the things that we're looking at is both specifying a minimal set of things.",
                    "label": 0
                },
                {
                    "sent": "That's that short note up there, but the other thing that we're talking about is for some papers, one of the ideas that we've been bandying about is having, in addition to, say, a specified statistical review.",
                    "label": 0
                },
                {
                    "sent": "In some cases, having a specified reproducibility review and saying if you've got something particularly in the New England Journal or Nature Medicine where it might lead to a clinical trial, you send it off to a group and say, OK, your job as a reviewer is simply to run the code and say does it generate the figures that show up in the paper?",
                    "label": 0
                },
                {
                    "sent": "Does it do that?",
                    "label": 0
                },
                {
                    "sent": "And that's going to delegate the workload and may if people know that it's going to be checked for reproducibility before it's published, the chance of actually getting that code and documentation is orders of magnitude better, so that's.",
                    "label": 0
                },
                {
                    "sent": "Our best fixed that yes it is a problem, but we're trying to address that.",
                    "label": 0
                },
                {
                    "sent": "OK, so you gave one very detailed example of one group which both was appalling in its systematic aspects.",
                    "label": 0
                },
                {
                    "sent": "Ann and the implications of the clinical trial.",
                    "label": 0
                },
                {
                    "sent": "But how often?",
                    "label": 0
                },
                {
                    "sent": "I assume that that's not the only thing that you tried.",
                    "label": 0
                },
                {
                    "sent": "How often do you see such mistakes on this example?",
                    "label": 0
                },
                {
                    "sent": "We have frequently seen mistakes that involve column transpositions, Rd transpositions in some cases with quantification, matrices, column offsets, and I've seen these in datasets that have come to me within MD Anderson.",
                    "label": 0
                },
                {
                    "sent": "You will never see these datasets.",
                    "label": 0
                },
                {
                    "sent": "They have never left MD Anderson before I fixed them.",
                    "label": 0
                },
                {
                    "sent": "They we have also seen these in other papers in the literature.",
                    "label": 0
                },
                {
                    "sent": "Most of the time you won't see us talking about those too many because we haven't looked at anywhere at most of them anywhere near this level of depth, and we can't because actually reconstructing this takes a hell of a lot of time.",
                    "label": 0
                },
                {
                    "sent": "We estimated that this took us somewhere between 1500 and 2000 hours to figure out how all this worked.",
                    "label": 0
                },
                {
                    "sent": "And the only reason we went into that level of detail here was because of the direct clinical application.",
                    "label": 0
                },
                {
                    "sent": "And because of the requests from clinical peas at MD Anderson.",
                    "label": 0
                },
                {
                    "sent": "We know that some of the simple mistakes are common.",
                    "label": 0
                },
                {
                    "sent": "I won't even as a first pass, I tend not to try to use too many micro experiments before 2005 because the rate of complete confounding is so high.",
                    "label": 0
                },
                {
                    "sent": "If you've got Affymetrix datasets, one of the things you can do from the cell files, as you can pull out the run dates from the headers and you can plot things that way to see if that's a problem.",
                    "label": 0
                },
                {
                    "sent": "Yes, there are other simple problems like that.",
                    "label": 0
                },
                {
                    "sent": "We know that they are more widespread than just this example.",
                    "label": 0
                },
                {
                    "sent": "So we know it needs to be fixed.",
                    "label": 0
                },
                {
                    "sent": "We still refer to this as our example case study because it tends to focus the attention.",
                    "label": 0
                },
                {
                    "sent": "Colin has a question.",
                    "label": 0
                },
                {
                    "sent": "We've had this sort of problem elsewhere.",
                    "label": 0
                },
                {
                    "sent": "Ions in science and one policy.",
                    "label": 0
                },
                {
                    "sent": "It was sort of adopted is that two separate groups who do not interact actually analyze the data or derive the theorem whatever, totally separately, because when people make mistakes, so tend to fly off at a tangent all over the place, so they do not make the same mistake if they're totally separate groups.",
                    "label": 0
                },
                {
                    "sent": "So it's a reasonable strategy that is a reasonable strategy, particularly if you're just talking about the analysis actually, to a certain extent, having somebody else be independently able to reproduce the analysis as I was just mentioning for an IRB approval.",
                    "label": 0
                },
                {
                    "sent": "That's one thing that we would really like to see in particular before going to clinical trials.",
                    "label": 0
                },
                {
                    "sent": "Having some other group try to at least qualitatively reproduce the findings as qualitatively not just exactly reproduce the analytical results that would.",
                    "label": 0
                },
                {
                    "sent": "That's also something we would find very reassuring, so we would love to see it.",
                    "label": 0
                },
                {
                    "sent": "It's not often done.",
                    "label": 0
                },
                {
                    "sent": "OK.",
                    "label": 0
                },
                {
                    "sent": "So thank you again.",
                    "label": 0
                },
                {
                    "sent": "Not only for the talk, but also for doing all that work.",
                    "label": 0
                }
            ]
        }
    }
}